摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-diethylterephthalamide | 6780-98-9

中文名称
——
中文别名
——
英文名称
N,N'-diethylterephthalamide
英文别名
N,N'-Diethyl-terephthalsaeure-diamid;1-N,4-N-diethylbenzene-1,4-dicarboxamide
N,N'-diethylterephthalamide化学式
CAS
6780-98-9
化学式
C12H16N2O2
mdl
——
分子量
220.271
InChiKey
AZSHNMRQTPKUKA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    58.2
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    N,N'-diethylterephthalamide氯化亚砜 作用下, 以 二氯甲烷 为溶剂, 生成 N,N,N',N'-tetraethyl-terephthalimidamide
    参考文献:
    名称:
    手性氢键超分子胶囊:C 70的合成,表征和络合
    摘要:
    通过新型双磷酸(R,R)-6与合适的双和三s啶的多组分自组装产生了两个超分子纳米胶囊。所得的手性氢键胶囊即使在极性介质中和低浓度下也稳定,可用于溶液中C 70-富勒烯的结合。
    DOI:
    10.1039/c8cc10152c
  • 作为产物:
    描述:
    乙胺对苯二甲酰氯 为溶剂, 反应 0.5h, 以90%的产率得到N,N'-diethylterephthalamide
    参考文献:
    名称:
    手性氢键超分子胶囊:C 70的合成,表征和络合
    摘要:
    通过新型双磷酸(R,R)-6与合适的双和三s啶的多组分自组装产生了两个超分子纳米胶囊。所得的手性氢键胶囊即使在极性介质中和低浓度下也稳定,可用于溶液中C 70-富勒烯的结合。
    DOI:
    10.1039/c8cc10152c
点击查看最新优质反应信息

文献信息

  • Molecular Pairs and A Propeller Containing Quadruply Bonded Dimolybdenum Units Linked by Polyamidate Ligands
    作者:F. Albert Cotton、Zhong Li、Chun Y. Liu、Carlos A. Murillo
    DOI:10.1021/ic0614723
    日期:2006.11.1
    Electrochemical measurements of these complexes show unresolved redox waves, which indicate that the dimetal centers are only electronically weakly coupled. Compound 1 was chemically oxidized by ferrocenium tetrafluoroborate to the two-electron oxidation product 4, where one electron was removed from each of the [Mo2] units. The hyperfine coupling in the EPR spectrum (A = 22 x 10-4 cm-1 ) suggests that 4 is an
    两个分子对[Mo2(DAniF)3] 2 [N,N'-对苯二甲酸乙二酰胺](1)和[Mo2(DAniF)3] 2 1,3-C6H4 [C(O)NP]}(2)其中DAniF = N,N'-二对茴香基甲酰胺基)和螺旋桨([Mo2(DAniF)3] 3 1,3,5-C6H3 [C(O)NPh] 3}(3))已经准备好通过将Mo2(DAniF)3(O2CCH3)与相应的聚酰胺酸酯直接结合,可得到高纯度的产品。这些配合物的电化学测量显示出未解析的氧化还原波,这表明双金属中心仅在电子上弱耦合。化合物1被四氟硼酸铁化学氧化成二电子氧化产物4,其中从每个[Mo2]单元中除去一个电子。EPR光谱中的超精细耦合(A = 22 x 10-4 cm-1)表明,4是一种电子俘获物种,在两个二钼单元中的每一个上都有一个电子,
  • SMAC MIMETIC DIMERS AND TRIMERS USEFUL AS ANTI-CANCER AGENTS
    申请人:HANSON Gunnar
    公开号:US20090104151A1
    公开(公告)日:2009-04-23
    The invention provides small molecule mimics of the Smac peptide that are dimer-like or trimer-like compounds having two or three amide-containing domains connected by a linker. These compounds are useful to promote apoptosis. The invention includes pharmaceutical compositions comprising such compounds and methods to use them to treat conditions including cancer and autoimmune disorders.
    本发明提供了Smac肽的小分子模拟物,这些模拟物是二聚体或三聚体化合物,具有由连接剂连接的两个或三个含酰胺的结构域。这些化合物对促进细胞凋亡很有用。本发明还包括包含这些化合物的药物组成物和使用它们治疗包括癌症和自身免疫性疾病在内的疾病的方法。
  • Smac mimetic dimers and trimers useful as anti-cancer agents
    申请人:Joyant Pharmaceuticals, Inc.
    公开号:US20140127155A1
    公开(公告)日:2014-05-08
    The invention provides small molecule mimics of the Smac peptide that are dimer-like or trimer-like compounds having two or three amide-containing domains connected by a linker. These compounds are useful to promote apoptosis. The invention includes pharmaceutical compositions comprising such compounds and methods to use them to treat conditions including cancer and autoimmune disorders.
    这项发明提供了Smac肽的小分子类似物,它们是二聚体或三聚体化合物,具有由连接剂连接的两个或三个含酰胺的结构域。这些化合物有助于促进细胞凋亡。该发明包括包含这些化合物的药物组合物和使用它们治疗癌症和自身免疫性疾病等病症的方法。
  • Modifiable polyunsaturated polymers and processes for their preparation
    申请人:Parthiban Anbanandam
    公开号:US20060189774A1
    公开(公告)日:2006-08-24
    The present invention relates to modifiable linear polyunsaturated polymers and processes for preparing the same comprising reacting solely at least one bifunctional nucleophilic compound with at least one α-functional unsaturated monomer. The at least one bifunctional nucleophilic compound of the invention comprises two nucleophiles independently selected from the group consisting of C, N, O, S and Se. The at least one α-functional unsaturated monomer of the invention comprises two leaving groups L 1 and L 2 , wherein at least one of the leaving groups L 1 and L 2 of the at least one α-functional unsaturated monomer is part of the nonaromatic unsaturated structure C═C—C α -L. The double bond of said α-functional unsaturated monomer is maintained in the polyunsaturated polymer.
    本发明涉及可改性线性多不饱和聚合物以及制备该聚合物的工艺,包括仅使至少一种双官能团亲核化合物与至少一种α官能团不饱和单体反应。本发明的至少一种双官能团亲核化合物包括两个独立选自 C、N、O、S 和 Se 组的亲核物。本发明的至少一种 α-官能团不饱和单体包括两个离去基团 L 1 和 L 2 其中至少一个离去基团 L 1 和 L 2 的至少一个离去基团 L 1 和 L 2 是非芳香族不饱和结构 C═C-C α -L.所述 α-官能团不饱和单体的双键保留在多不饱和聚合物中。
  • Hydrophobic, Salt-Like Structured Silicate
    申请人:Michel Eduard
    公开号:US20080107986A1
    公开(公告)日:2008-05-08
    A salt-like hydrophobic structured silicate, wherein the cation of the salt-like structured silicate is a low molecular weight organic cation or a combination thereof with NH 4 + , H 3 O + , alkali metal, alkaline earth metal, earth metal and/or a transition metal ion. The anion of the salt-like structured silicate is an island, ring, group, chain, band, layer or tectosilicate or a combination thereof. The structured silicate is produced by (a) reacting a structured silicate, whose cation is NH 4 + , H 3 O + , an alkali metal, alkaline earth metal, earth metal, and/or transition metal ion or a combination thereof, and whose anion of which is an island, ring, group, chain, band, layer or tectosilicate, or a combination thereof, in an aqueous dispersion with a low molecular weight organic cation; (b) adding to and intensively blending with the aqueous structured silicate dispersion a hydrophobic compound from the group of waxes and metal soaps in a quantity ranging from 0.2 to 200% by weight of the salt-like structured silicate in step (a) before, during and/or after step(a) is carried out and by (c) optionally removing, drying and isolating in the form of a powder the salt-like, hydrophobic structured silicate produced in step (b).
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐